Calcium supplementation and bone loss: a review of controlled clinical trials
Abstract
The responsiveness of postmenopausal women to supplementation with calcium appears to depend on their menopausal age. In women who are within the first 5 y of menopause, bone loss from the radius is attenuated but not arrested by added calcium. The maximal effect appears to occur with supplement dosages of approximately 1000 mg elemental Ca/d. In contrast, the spine is unresponsive to supplementation with calcium even at higher doses in early postmenopausal women. In late postmenopausal women, bone loss from the radius is attenuated by increased calcium intake. Loss from the spine can be retarded by increasing calcium intake to the current recommended dietary allowance in older women with low usual calcium diets. The effect of supplementation with higher doses of calcium in this segment of the population is unknown. Finally, the effect of added calcium on hip density of postmenopausal women is not yet established.
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Benign periarticular, bone and joint lipomatous lesions
- A review of the physiological and histological effects of laser osteotomy
- Quality of bone healing: perspectives and assessment techniques
- Effects of bioactive lipids and lipoproteins on bone
- Bone structure and function
- Quantifying bone structure, micro-architecture, and pathophysiology with MRI.
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.